An established ex vivo 3D culture platform using patient-derived xenograft (PDX) tumors replicate the anti-tumor efficacy observed in vivo

被引：0
|
作者：
Xu, Xiaoxi
Zhang, Wenna
Xie, Bingying
Bao, Zheng Zheng
Mei, Zhu
Wery, Jean-Pierre
Ning, Jinying
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
609
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Poor-Risk AML with Complex, Monosomal Karyotype: In Vivo Therapeutic Efficacy of Decitabine (DAC) in Patient-Derived Xenograft (PDX) Mouse Models
    Greve, Gabriele
    Schuler, Julia
    Oswald, Eva
    Lubbert, Michael
    BLOOD, 2019, 134
  • [32] Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies
    Eckhardt, Bedrich L.
    Gagliardi, Maria
    Iles, LaKesla
    Evans, Kurt
    Ivan, Cristina
    Liu, Xiuping
    Liu, Chang-Gong
    Souza, Glauco
    Rao, Arvind
    Meric-Bernstam, Funda
    Ueno, Naoto T.
    Bartholomeusz, Geoffrey A.
    PLOS ONE, 2018, 13 (05):
  • [33] DETERMINING THE EFFICACY OF ADCC BY THE 3D-EX EX VIVO PLATFORM UTILIZING TUMOROIDS OF FRESH PATIENT TUMOR SAMPLES WITH INTACT TUMOR MICROENVIRONMENT
    Kreahling, Jenny
    Ehrhart, Jared
    Iwanowycz, Stephen
    Pabon, Mibel
    Pastoor, Tina
    Altiok, Soner
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A336 - A336
  • [34] ITCC-P4: GENOMIC PROFILING AND ANALYSES OF PEDIATRIC PATIENT TUMOR AND PATIENT-DERIVED XENOGRAFT (PDX) MODELS FOR HIGH THROUGHPUT IN VIVO TESTING.
    Gopisetty, Apurva
    Federico, Aniello
    Surdez, Didier
    Saberi-Ansari, Elnaz
    Iddir, Yasmine
    Saint-Charles, Alexandra
    Waterfall, Joshua
    Wierzbinska, Justyna
    Schlicker, Andreas
    Mack, Norman
    Schwalm, Benjamin
    Jones, David T.
    Gojo, Johannes
    Chesler, Louis
    Vassal, Gilles
    Stancato, Lou
    Koster, Jan
    Molenaar, Jan J.
    Jaeger, Natalie
    Schleiermacher, Gudrun
    Pfister, Stefan
    Kool, Marcel
    NEURO-ONCOLOGY, 2022, 24 : 126 - 127
  • [35] Patient-Derived Tumor Xenografts Plus Ex Vivo Models Enable Drug Validation for Tenosynovial Giant Cell Tumors
    Fan Tang
    Yan Tie
    Wei-Qi Hong
    Xin He
    Li Min
    Yong Zhou
    Yi Luo
    Si-Yuan Chen
    Jing-Yun Yang
    Hou-Hui Shi
    Xia-Wei Wei
    Chong-Qi Tu
    Annals of Surgical Oncology, 2021, 28 : 6453 - 6463
  • [36] Patient-Derived Tumor Xenografts Plus Ex Vivo Models Enable Drug Validation for Tenosynovial Giant Cell Tumors
    Tang, Fan
    Tie, Yan
    Hong, Wei-Qi
    He, Xin
    Min, Li
    Zhou, Yong
    Luo, Yi
    Chen, Si-Yuan
    Yang, Jing-Yun
    Shi, Hou-Hui
    Wei, Xia-Wei
    Tu, Chong-Qi
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6453 - 6463
  • [37] Measuring immunotherapy responses ex vivo using novel 3D culture platform: E-slice
    Gallup, Thomas D.
    Maldonado, Jose A.
    Margain, Corina
    Kim, Min P.
    Gallup, David F.
    Yun, Kyuson
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model
    Yang, Cheng-Yu
    Lin, Chih-Kung
    Hsieh, Cheng-Chih
    Tsao, Chang-Huei
    Lin, Chun-Shu
    Peng, Bo
    Chen, Yen-Tzu
    Ting, Chun-Chieh
    Chang, Wei-Chin
    Lin, Gu-Jiun
    Sytwu, Huey-Kang
    Chen, Yuan-Wu
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (05): : 1260 - 1269
  • [39] 3D patient-derived tumor models to recapitulate pediatric brain tumors In Vitro
    Tang-Schomer, Min D.
    Chandok, Harshpreet
    Wu, Wei-Biao
    Lau, Ching C.
    Bookland, Markus J.
    George, Joshy
    TRANSLATIONAL ONCOLOGY, 2022, 20
  • [40] Predicting drug sensitivity in patient derived ex vivo 3D mesothelioma cultures
    Cornelissen, Robin
    Dumouline, Daphne
    Thusen, Janvd
    Basten, Sander
    Grillet, Fanny
    Yan, Kuan
    Price, Leo
    Vader, Willemijn
    CANCER RESEARCH, 2019, 79 (13)
12345